The short answer
Often yes, as long as your dose is a maintenance dose and not a starter step. Zepbound lists 5 mg, 10 mg or 15 mg as maintenance; the Wegovy shot lists 1.7 mg or 2.4 mg; Ozempic and Mounjaro go up only if more blood sugar control is needed. Starting doses such as Zepbound 2.5 mg or Wegovy 0.25 mg are not maintenance doses. Whether to stop climbing is your prescriber’s call, made with you, based on results and side effects.
At GLP-1 SOS this question usually arrives around month three, from people who are doing well: “I am losing steadily on 5 mg, the nausea is finally manageable, and my next pen is a higher dose. Do I have to go up?” The escalation schedule is a ceiling to work toward, not a staircase you must climb to the top. The labels say so. They also say some lower doses are only there to get you started.
At a glance
Three things the labels actually say
1
Starter doses are not the goal
Zepbound 2.5 mg is “not approved as a maintenance dosage.” Wegovy 0.25 mg to 1 mg are escalation steps.
2
There is more than one maintenance dose
Zepbound: 5, 10 or 15 mg. Wegovy shot: 1.7 or 2.4 mg, with 7.2 mg as an option. Ozempic: 0.5, 1 or 2 mg.
3
Response and tolerability decide
Both makers tell prescribers to weigh your response and tolerability when choosing.
What the dosing sections say
Every GLP-1 label starts low and steps up to reduce stomach side effects, then names the doses meant for the long term. Zepbound starts at 2.5 mg for four weeks, then 5 mg, with optional 2.5 mg steps after at least four weeks. Its maintenance dose for weight reduction is 5 mg, 10 mg or 15 mg, and the label says: “Consider treatment response and tolerability when selecting the maintenance dosage.”
The Wegovy shot climbs from 0.25 mg over 16 weeks. Its maintenance dose for weight reduction in adults is 1.7 mg or 2.4 mg (2.4 mg recommended), with 7.2 mg possible after four weeks on 2.4 mg if more loss is clinically indicated. Wegovy tablets have one maintenance dose, 25 mg; if it is not tolerated, the label suggests the 1.7 mg shot. Ozempic and Mounjaro, diabetes medicines, go up only if more blood sugar control is needed. Foundayo reaches 5.5 mg, then may go higher based on response and tolerability.
Lab note
The schedule tells you the fastest safe way up. It does not tell you that you must go all the way.
Higher doses do mean more weight loss on average. In the main Zepbound trial, people lost 15.0% of their weight on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg at 72 weeks, against 3.1% on placebo. Nausea was 25%, 29% and 28%, so 5 mg was not much gentler on the stomach. It is a trade-off for you and your prescriber, not a rule. Compounded semaglutide and tirzepatide have no FDA-approved label, so there is no labeled maintenance dose to point to.
From the labels
The numbers behind the choice
15.0%
average weight lost on Zepbound 5 mg at 72 weeks, versus 20.9% on 15 mg and 3.1% on placebo, per the Zepbound label
1.7 mg
the lower labeled maintenance dose of the Wegovy shot; 2.4 mg is recommended and 7.2 mg is an option, per the Wegovy label
4 weeks
the minimum time on a dose before the next step for Zepbound, Mounjaro and Ozempic, per their labels
Sources: Zepbound Prescribing Information, August 2026; Wegovy Prescribing Information, June 2026; Mounjaro Prescribing Information, August 2026; Ozempic Prescribing Information, May 2026.
What to do
- Find your dose on the label. Ask your prescriber or pharmacist: is this a maintenance dose for my medication and condition, or a starter step?
- Bring numbers, not a feeling. Note your weight trend over 8 to 12 weeks, hunger and side effects. With diabetes, bring your A1C or glucose readings.
- Ask what success looks like at this dose. Agree on a goal and a check-in date. If progress stalls for months, read whether a plateau is normal.
- If you go up, expect a rough week or two. Side effects often come back for a while after a step. Read what is normal after a dose increase before your next pen.
- Do not stretch or split doses to stay lower. Skipping weeks, using part of a pen or spacing shots further apart is not a lower dose. No label covers it.
- Keep the habits that make any dose work. Protein at each meal, water, fiber and movement matter at every dose, and more if you stay lower.
- Know when to call. Severe stomach pain, vomiting you cannot stop or signs of low blood sugar mean a call, at any dose.

From our support desk at GLP-1 SOS
If you wrote to us tonight about this, here is what we would say.
Staying on a dose that works is a good outcome, not a failure to keep up, and it is your prescriber’s call to make with you. Ask one question at your next visit: is this a maintenance dose for me? Then protect the routine that got you here. That is what we built GLP-1 SOS Daily Gut Relief for: 2 capsules with dinner, with magnesium that supports regular bowel movements and ginger and peppermint that support digestive comfort.* If you prefer no supplements, water, fiber from food and a short walk after meals cover a lot of the same ground.
We answer real questions from real people every day. Write to us if yours is not here.
*GLP-1 SOS Daily Gut Relief supports regular bowel movements and digestive comfort. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Two situations
A reasonable place to stay, or a talk first
Often reasonable to discuss staying
- Zepbound 5 mg or 10 mg with steady progress
- Wegovy 1.7 mg with steady progress
- Ozempic or Mounjaro with your A1C at goal
- Side effects that are finally manageable
Talk to your prescriber first
- Staying on Zepbound 2.5 mg or Wegovy 0.25 to 1 mg
- No progress for several months
- Side effects that are still severe
- A compounded dose you measure yourself
Never change your dose on your own. Ask whether your dose is a maintenance dose.
When to call your doctor
Call your prescriber the same day if:
- You have severe stomach pain that will not go away, sometimes spreading to your back
- You have upper stomach pain with fever, yellowing skin or eyes, or clay-colored stools
- You cannot keep fluids down, or vomiting or diarrhea will not stop
- You have shakiness, sweating or confusion and take insulin or a sulfonylurea
- You have swelling of the face, lips or throat, or trouble breathing
- You missed two or more weekly doses and are unsure how to restart
The right dose is the one that works for you and that you and your prescriber chose together.

From the people behind the Lab
You do not have to figure this out alone.
GLP-1 SOS is the daily companion made for life on a GLP-1. Plain answers like this one, a support team that replies to real questions from real people, and daily formulas like GLP-1 SOS Daily Gut Relief, designed around the side effects that come with the medication. The GLP-1 Lab is our free education arm: no login, no paywall, no hype. Side effects are part of the road. Suffering through them is not.
Questions people also ask
Can I stay on 5 mg of Zepbound or Mounjaro?
For Zepbound, 5 mg is a labeled maintenance dose for weight reduction, along with 10 mg and 15 mg, and the label tells prescribers to weigh response and tolerability. In the main trial, 5 mg averaged 15.0% weight loss at 72 weeks. Mounjaro, a diabetes medicine, goes up only if more blood sugar control is needed. Either way, staying is a decision for you and your prescriber.
Can I stay on 1.7 mg of Wegovy instead of 2.4 mg?
Yes, 1.7 mg is one of the two labeled maintenance doses of the Wegovy shot for weight reduction in adults; 2.4 mg is the recommended one. The label tells prescribers to consider response and tolerability. On Wegovy tablets, if 25 mg is not tolerated, the label suggests switching to the 1.7 mg shot. Ask your prescriber which fits your goals.
Can I stay on a low dose of Ozempic if my blood sugar is good?
The Ozempic label lists 0.5 mg, 1 mg and 2 mg as maintenance doses and raises the dose only if more blood sugar control is needed after at least four weeks. So staying at 0.5 mg or 1 mg with your A1C at goal follows the label. The 0.25 mg dose is for the first four weeks only. Your prescriber decides from your readings.
Is it bad to stay on the starting dose of a GLP-1?
Starting doses let your stomach adjust. The Zepbound label says 2.5 mg is not approved as a maintenance dose, and Wegovy 0.25 mg to 1 mg are escalation steps. Some prescribers keep people lower for longer for good reasons, but that is outside the label, so ask yours to explain the plan. Never stay low by skipping doses or using part of a pen.
Will I lose less weight on a lower GLP-1 dose?
On average, yes. In the main Zepbound trial, people lost 15.0% on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg at 72 weeks. Averages hide a wide range, and nausea rates were similar across those doses. If your weight stalls for months, read why a GLP-1 can seem to stop working and take it to your prescriber.
Sources (6)
- Zepbound (tirzepatide) injection, Prescribing Information. Eli Lilly, revised August 2026.
- Wegovy (semaglutide) injection and tablets, Prescribing Information. Novo Nordisk / FDA, revised June 2026.
- Mounjaro (tirzepatide) injection, Prescribing Information. Eli Lilly, revised August 2026.
- Ozempic (semaglutide) injection, Prescribing Information. Novo Nordisk, revised May 2026.
- Foundayo (orforglipron) tablets, Prescribing Information. Eli Lilly, revised July 2026.
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. U.S. Food and Drug Administration, content current as of October 1, 2026.
Reviewed by the GLP-1 SOS editorial team · Education, not medical advice · Talk to your prescriber about your dose and your symptoms.



